Nueno Carlos 4

What Happened
Carlos Nueno, President, International at Teladoc Health (TDOC), had restricted stock units (RSUs) convert to common shares on June 1, 2026, and subsequently sold shares in the open market to cover tax withholding. The Form 4 shows conversion/exercise-type entries for 4,556 and 8,716 shares (RSU conversions) on 2026-06-01, and an open-market sale of 6,196 shares on 2026-06-02 at $7.63 per share, yielding $47,257. Several derivative/zero-dollar disposition entries on 6/1 reflect the conversion/withholding activity tied to the vesting.

Key Details

• Transaction dates and amounts:
  • 2026-06-01: RSU conversion/exercise entries for 4,556 and 8,716 shares (reported as derivative "M" transactions).
  • 2026-06-02: Open market sale of 6,196 shares at $7.63 each, total proceeds $47,257.
• Shares owned after transaction: Not specified in the filing.
• Footnotes of note:
  • F1: RSUs convert one-for-one into TDOC common stock.
  • F2: The open-market sale was to cover tax withholding on vested RSUs.
  • F3/F4: Background on RSU grants — 54,675 RSUs granted 3/19/2024 (staged vesting) and 104,602 RSUs granted 3/1/2025 (staged vesting).
• Filing timing: Form filed 2026-06-03 reporting transactions on 2026-06-01–06-02; no late filing is indicated in the document.

Context

• The "M" transaction code indicates exercise or conversion of a derivative security; here that means RSUs vested and converted into common shares.
• The single open-market sale appears to be a routine "sell to cover" tax obligation after vesting, not necessarily an independent discretionary sale signal.
• These filings are factual disclosures of insider holdings/activity and do not, by themselves, indicate management’s view of the company’s prospects.